Transchem Stock Screener | Share Price & Fundamental Analysis
TRANSCHEM
Pharmaceuticals
Screen Transchem share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹190.40
▼
-3.85 (-1.98%)
Market Cap
₹206.10 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
2.54
EPS (TTM)
₹4.27
Dividend Yield
-
Debt to Equity
-
52W High
₹194.25
52W Low
₹32.82
Operating Margin
-44.00%
Profit Margin
40.00%
Revenue (TTM)
₹10.00
EBITDA
₹5.00
Net Income
₹4.00
Total Assets
₹80.00
Total Equity
₹79.00
Transchem Share Price History - Stock Screener Chart
Screen TRANSCHEM historical share price movements with interactive charts. Analyze price trends and patterns.
Transchem Company Profile - Fundamental Screener
Screen Transchem company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TRANSCHEM shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE019B01010
Transchem Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen TRANSCHEM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 80 | 76 | 66 | 67 | 63 | 37 | 38 | 37 | 38 | 39 |
| Current Assets | 78 | 67 | 58 | 58 | 55 | 30 | 28 | 30 | 29 | 28 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 4 | 4 | 5 | 6 | 7 |
| Liabilities | ||||||||||
| Total Liabilities | 80 | 76 | 66 | 67 | 63 | 37 | 38 | 37 | 38 | 39 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 79 | 76 | 66 | 66 | 63 | 37 | 38 | 37 | 38 | 38 |
| Share Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
| Reserves & Surplus | 67 | 63 | 54 | 54 | 51 | 25 | 26 | 25 | 26 | 26 |
Screen TRANSCHEM income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10 | 11 | 8 | 4 | 7 | 27 | 3 | 3 | 2 | 2 | 2 | 2 |
| Expenses | 4 | 4 | 2 | 2 | 3 | 2 | 1 | 1 | 2 | 1 | 1 | 1 |
| EBITDA | 5 | 7 | 6 | 3 | 4 | 25 | 1 | 2 | 0 | 1 | 1 | 1 |
| Operating Profit % | -44.00% | -56.00% | -423.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 5 | 7 | 6 | 3 | 4 | 25 | 1 | 1 | -1 | 0 | 0 | 0 |
| Tax | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
| Net Profit | 4 | 5 | 4 | 1 | 3 | 24 | 0 | 0 | -1 | 0 | 0 | 0 |
| EPS | 3.10 | 4.27 | 3.43 | 1.01 | 2.34 | 19.73 | 0.33 | 0.25 | -0.97 | -0.18 | 0.04 | 0.10 |
Transchem Cash Flow Screener - Liquidity Fundamentals
Screen TRANSCHEM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 36 | -39 | 1 | 22 | -28 | -1 | 10 | -20 | 1 | 1 |
| Investing Activities | 6 | 5 | -1 | 1 | 23 | 1 | 6 | 20 | -2 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 42 | -34 | 0 | 23 | -5 | 0 | 16 | 0 | -1 | 1 |
Screen TRANSCHEM shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 56.45% | 56.45% | 56.45% | 51.68% | 51.68% | 51.68% | 51.68% | 49.69% |
| FII Holding | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.00% |
| DII Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.69% | 24.75% | 23.38% | 27.15% | 27.22% | 27.37% | 27.32% | 26.73% |
| Other Holding | 18.83% | 18.76% | 20.14% | 21.14% | 21.07% | 20.92% | 20.97% | 23.57% |
| Shareholder Count | 13,843 | 13,767 | 13,680 | 13,813 | 13,681 | 13,647 | 13,835 | 13,482 |
Transchem Dividend Screener - Share Yield Analysis
Screen TRANSCHEM dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Transchem Index Membership - Market Screener Classification
Screen TRANSCHEM by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Transchem Market Events Screener - Corporate Actions
Screen TRANSCHEM market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-12-20 | 2025-12-20 | Extraordinary General Meeting | NA | 126.06% |
| 2025-10-16 | 2025-10-16 | Extraordinary General Meeting | NA | -17.83% |
| 2025-10-16 | 2025-10-16 | Quarterly Result Announcement | NA | -1.48% |
| 2025-08-23 | 2025-08-23 | Annual General Meeting | NA | 15.27% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | 2.20% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | -1.96% |
| 2025-01-28 | 2025-01-28 | Quarterly Result Announcement | NA | -7.99% |
| 2024-10-15 | 2024-10-15 | Quarterly Result Announcement | NA | 9.22% |
| 2024-08-24 | 2024-08-24 | Annual General Meeting | NA | -5.31% |
Transchem Competitors Screener - Peer Comparison
Screen TRANSCHEM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 418,660 | 39.93 | 54,729 | 9.71% | 10,980 | 42.57 |
| Divis Laboratories | 171,984 | 69.20 | 9,712 | 18.67% | 2,191 | 54.31 |
| Torrent Pharmaceuticals | 128,619 | 60.10 | 11,539 | 6.99% | 1,911 | 59.28 |
| Cipla | 122,544 | 22.55 | 28,410 | 7.12% | 5,291 | 51.13 |
| Dr Reddys Laboratories | 106,680 | 18.60 | 33,741 | 16.73% | 5,725 | 57.95 |
| Lupin | 97,097 | 22.34 | 22,910 | 13.74% | 3,306 | 65.19 |
| Zydus Life Science | 92,533 | 18.40 | 23,511 | 18.55% | 4,615 | 40.83 |
| Mankind Pharma | 89,655 | 50.59 | 12,744 | 20.90% | 2,007 | 42.47 |
| Aurobindo Pharma | 71,154 | 20.79 | 32,346 | 9.43% | 3,484 | 60.10 |
| Alkem Laboratories | 66,424 | 27.59 | 13,458 | 3.70% | 2,216 | 43.27 |
Transchem Company Announcements - News Screener
Screen TRANSCHEM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-06 | Shareholder Meeting / Postal Ballot-Outcome of EGM | View |
| 2026-01-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-01-01 | Corrigendum To The Notice Of The 2Nd Extra-Ordinary General Meeting Of The Members Of Transchem Limited For The Financial Year 2025-26 Scheduled To Be Held On Saturday December 20 2025. | View |
| 2025-11-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-27 | Notice Of The 2Nd Extra-Ordinary General Meeting Of The Members Of The Company For The Financial Year 2025-2026 | View |
| 2025-11-21 | Announcement under Regulation 30 (LODR)-Preferential Issue | View |
| 2025-11-21 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | View |
| 2025-11-21 | Board Meeting Outcome for Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 Held On November 21 2025 | View |
| 2025-11-18 | Closure of Trading Window | View |
| 2025-11-18 | Board Meeting Intimation for Proposal For Raising Of Funds And Convening An Extra-Ordinary General Meeting. | View |
| 2025-10-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-16 | Announcement under Regulation 30 (LODR)-Acquisition | View |
| 2025-10-16 | Un-Audited Financial Results Of The Company For The Quarter And Half-Year Ended September 30 2025 Along With Limited Review Report. | View |
| 2025-10-16 | Board Meeting Outcome for Outcome Of The Board Meeting Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Held On October 16 2025. | View |
| 2025-10-16 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | View |
| 2025-10-16 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-10-16 | Shareholder Meeting / Postal Ballot-Outcome of EGM | View |
| 2025-10-14 | Intimation Of Change In Email ID Of CompanyS Registrar And Share Transfer Agent | View |
| 2025-10-10 | Board Meeting Intimation for Approval Of Un-Audited Financial Results Of The Company For The Quarter And Half-Year Ended September 30 2025 | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |